surmount-osa tirzepatide results in Obesity-Related Obstructive Sleep Apnea: Beyond Weight Loss Toward Disease Modification? MelodyScott Hoppius | ✨ What

We recently partnered with a leading software company to combine behavioral support with targeted GLP1 access

For MACE-4, the HR was 0.80 (95% CI, 0.571.11) for tirzepatide versus standard therapy, the HR for cardiovascular death 0.90 (95% CI, 0.501.61) and 0.80 (95% CI, 0.511.25) for all-cause death

The Not-So-Good : They arent always the most effective for treating established GLP-1 constipation but can be helpful in preventing it or for mild cases of difficulty passing stool on GLP-1

myPEPT supplies this GH-secretagogue blend at 99% purity per component, accompanied by a Certificate of Analysis from third-party testing, and ships it lyophilised across the EU in research-grade packaging